Cannabidiol (CBD) is a novel inhibitor for Exosome and Microvesicle (EMV) release in cancer
Exosomes and microvesicles (EMV) are lipid bilayer-enclosed structures, released by cells and involved in intercellular communication through transfer of proteins and genetic material. EMV release is also associated with various pathologies, including cancer, where increased EMV release is amongst o...
Main Authors: | Kosgodage, Uchini S., Mould, Rhys, Henley, Aine B., Nunn, Alistair V., Guy, Geoffrey W., Thomas, E. Louise, Inal, Jameel, Bell, Jimmy D., Lange, Sigrun |
---|---|
Format: | Article |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.londonmet.ac.uk/3046/1/fphar-09-00889.pdf |
Similar Items
-
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
by: Uchini S. Kosgodage, et al.
Published: (2018-08-01) -
The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy
by: Moore, Colin, et al.
Published: (2017) -
Cannabidiol affects extracellular vesicle release, miR21 and miR126, and reduces prohibitin protein in glioblastoma multiforme cells
by: Kosgodage, Uchini S., et al.
Published: (2018) -
Inhibition of extracellular vesicle release enhances cancer chemotherapy and inhibition of outer membrane vesicle release sensitises bacteria to antibiotic and bacteriophage therapy
by: Kosgodage, Uchini S.
Published: (2019) -
A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy
by: Kholia, Sharadkumar Rajnikant, et al.
Published: (2015)